Stimulation of superoxide production increases fungicidal action of miconazole against Candida albicans biofilms

Scientific Reports

Volumn 6, Issue , 2016, Pages

  De Cremer, Kaat ^a,b   De Brucker, Katrijn ^a   Staes, Ines ^a   Peeters, Annelies ^a   Van Den Driessche, Freija ^c   Coenye, Tom ^c   Cammue, Bruno P A ^a,b   Thevissen, Karin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MICONAZOLE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

BIOFILM; CANDIDA ALBICANS; DRUG EFFECTS; GENETIC TRANSCRIPTION; METABOLISM;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; MICONAZOLE; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TRANSCRIPTION, GENETIC;

EID: 84976346980     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27463     Document Type: Article

References (75)

1. Ferrer, J. Vaginal candidosis: epidemiological and etiological factors. Int. J. Gynaecol. Obstet. 71 Suppl 1, S21-S27 (2000).
2. Sobel, J. D. Vulvovaginal candidosis. Lancet 369, 1961-1971 (2007).
3. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines. http://www.cdc.gov/std/tg2015/candidiasis.htm , (2015). Date of access: 10/06/2015.
4. Ghannoum, M. A. & Rice, L. B. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12, 501-517 (1999).
5. Akins, R. A. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med. Mycol. 43, 285-318 (2005).
6. Kobayashi, D. et al. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob. Agents Chemother. 46, 3113-7 (2002).
7. François, I. E. J. A. et al. Azoles: Mode of Antifungal Action and Resistance Development. Effect of Miconazole on Endogenous Reactive Oxygen Species Production in Candida albicans. Curr. Med. Chem.-Anti-Infective Agents 5, 3-13 (2006).
8. Xu, Y. et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: Endogenous ROS augmentation. J. Proteome Res. 8, 5296-5304 (2009).
9. Yan, L. et al. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility. J. Antimicrob. Chemother. 64, 764-73 (2009).
10. Vandenbosch, D., Braeckmans, K., Nelis, H. J. & Coenye, T. Fungicidal activity of miconazole against Candida spp. biofilms. J. Antimicrob. Chemother. 65, 694-700 (2010).
11. Bink, A. et al. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother. 55, 4033-7 (2011).
12. Belenky, P., Camacho, D. & Collins, J. J. Fungicidal Drugs Induce a Common Oxidative-Damage Cellular Death Pathway. Cell Rep. 3, 350-358 (2013).
13. Kim, J. H., Chan, K. L., Faria, N. C. G., Martins, M. de L. & Campbell, B. C. Targeting the oxidative stress response system of fungi with redox-potent chemosensitizing agents. Front. Microbiol. 3, 88 (2012).
14. Delattin, N., Cammue, B. & Thevissen, K. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med. Chem. 6, 77-90 (2014).
15. François, I. E. et al. Design and synthesis of a series of piperazine-1-carboxamidine derivatives with antifungal activity resulting from accumulation of endogenous reactive oxygen species. ChemMedChem 4, 1714-21 (2009).
16. Thevissen, K. et al. Fungicidal activity of truncated analogues of dihydrosphingosine. Bioorg. Med. Chem. Lett. 18, 3728-30 (2008).
17. Gardner, T. S., di Bernardo, D., Lorenz, D. & Collins, J. J. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301, 102-5 (2003).
18. Wecke, T. & Mascher, T. Antibiotic research in the age of omics: from expression profiles to interspecies communication. J. Antimicrob. Chemother. 66, 2689-704 (2011).
19. Shen, D.-W., Pouliot, L. M., Hall, M. D. & Gottesman, M. M. Cisplatin resistance: A cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol. Rev. 64, 706-21 (2012).
20. Vediyappan, G., Rossignol, T. & dEnfert, C. Interaction of Candida albicans biofilms with antifungals: Transcriptional response and binding of antifungals to beta-glucans. Antimicrob. Agents Chemother. 54, 2096-111 (2010).
21. Sanglard, D., Ischer, F., Monod, M. & Bille, J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416 (1997).
22. Mukherjee, P. K., Chandra, J., Kuhn, D. M. & Ghannoum, M. A. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71, 4333-40 (2003).
23. Ramage, G., Bachmann, S., Patterson, T. F., Wickes, B. L. & López-Ribot, J. L. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49, 973-980 (2002).
24. Yu, L. H., Wei, X., Ma, M., Chen, X. J. & Xu, S. B. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. Antimicrob. Agents Chemother. 56, 770-775 (2012).
25. Copping, V. M. S. et al. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. J. Antimicrob. Chemother. 55, 645-54 (2005).
26. Nailis, H. et al. Real-Time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and-independent gene expression. BMC Microbiol. 10, 114 (2010).
27. Fox, E. P. et al. Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures. Curr. Biol. 24, 2411-6 (2014).
28. Fox, E. P. et al. An Expanded Regulatory Network Temporally Controls Candida albicans Biofilm Formation. Mol. Microbiol. 96, 1226-39 (2015).
29. François, I. E. J. A. et al. Membrane rafts are involved in intracellular miconazole accumulation in yeast cells. J. Biol. Chem. 284, 32680-32685 (2009).
30. Vandenbosch, D. et al. Genomewide screening for genes involved in biofilm formation and miconazole susceptibility in Saccharomyces cerevisiae. FEMS Yeast Res. 13, 720-30 (2013).
31. Synnott, J. M., Guida, A., Mulhern-Haughey, S., Higgins, D. G. & Butler, G. Regulation of the hypoxic response in Candida albicans. Eukaryot. Cell 9, 1734-1746 (2010).
32. Martchenko, M., Alarco, A.-M., Harcus, D. & Whiteway, M. Superoxide dismutases in Candida albicans: Transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol. Biol. Cell 15, 456-67 (2004).
33. Frohner, I. E., Bourgeois, C., Yatsyk, K., Majer, O. & Kuchler, K. Candida albicans cell surface superoxide dismutases degrade hostderived reactive oxygen species to escape innate immune surveillance. Mol. Microbiol. 71, 240-52 (2009).
34. Lushchak, V., Semchyshyn, H., Lushchak, O. & Mandryk, S. Diethyldithiocarbamate inhibits in vivo Cu, Zn-superoxide dismutase and perturbs free radical processes in the yeast Saccharomyces cerevisiae cells. Biochem. Biophys. Res. Commun. 338, 1739-44 (2005).
35. Garcia-Cuesta, C., Sarrion-Pérez, M.-G. & Bagán, J. V. Current treatment of oral candidiasis: A literature review. J. Clin. Exp. Dent. 6, e576-82 (2014).
36. Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L. & Noverr, M. C. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156, 3635-44 (2010).
37. Darwazeh, A. M. G. & Darwazeh, T. A. What Makes Oral Candidiasis Recurrent Infection ? A Clinical View. 2014, doi: 10.1155/2014/758394 (2014).
38. García-Sánchez, S. et al. Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 3, 536-45 (2004).
39. Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W. & Nguyen, M. H. A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole. Antimicrob. Agents Chemother. 51, 1855-1858 (2007).
40. Sun, N. et al. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants. Antimicrob. Agents Chemother. 57, 532-42 (2013).
41. Onyewu, C., Blankenship, J. R., Del Poeta, M. & Heitman, J. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 47, 956-964 (2003).
42. Cunningham, K. W. & Fink, G. R. Calcineurin inhibits VCX1-dependent H+ /Ca2+ exchange and induces Ca2+ ATPases in Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 2226-37 (1996).
43. Ueno, K. et al. Intestinal resident yeast Candida glabrata requires Cyb2p-Mediated lactate assimilation to adapt in mouse intestine. PLoS One 6, e24759 (2011).
44. Bergman, P. W. & Björkhem-Bergman, L. Is there a role for statins in fungal infections? Expert Rev. Anti. Infect. Ther. 11, 1391-1400 (2013).
45. Kelly, S. et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol δ 5, 6-desaturation. FEBS Lett. 400, 80-82 (1997).
46. Nyilasi, I. et al. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS Microbiol. Lett. 307, 175-184 (2010).
47. Song, J. L., Lyons, C. N., Holleman, S., Oliver, B. G. & White, T. C. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Med. Mycol. 41, 417-425 (2003).
48. Naldi, L. & Diphoorn, J. Seborrhoeic dermatitis of the scalp. BMJ Clin. Evid. http://clinicalevidence.bmj.com/x/systematicreview/1713/overview.html , (2015). Date of Access: 08/07/2015.
49. Reeder, N. L. et al. Zinc pyrithione inhibits yeast growth through copper influx and inactivation of iron-sulfur proteins. Antimicrob. Agents Chemother. 55, 5753-60 (2011).
50. Turner, G. A. et al. Enhanced efficacy and sensory properties of an anti-dandruff shampoo containing zinc pyrithione and climbazole. Int. J. Cosmet. Sci. 35, 78-83 (2013).
51. Huang, L.-S., Cobessi, D., Tung, E. Y. & Berry, E. A. Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: A new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. J. Mol. Biol. 351, 573-97 (2005).
52. Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L. & Lesnefsky, E. J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278, 36027-31 (2003).
53. Chua, Y. L. et al. Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 285, 31277-84 (2010).
54. Ruy, F., Vercesi, A. E. & Kowaltowski, A. J. Inhibition of specific electron transport pathways leads to oxidative stress and decreased Candida albicans proliferation. J. Bioenerg. Biomembr. 38, 129-35 (2006).
55. Kasianowicz, J., Benz, R. & McLaughlin, S. The kinetic mechanism by which CCCP (carbonyl cyanidem-Chlorophenylhydrazone) transports protons across membranes. J. Membr. Biol. 82, 179-190 (1984).
56. Leloup, C. et al. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes 55, 2084-90 (2006).
57. Chaudhari, A. A., Seol, J.-W., Kang, S.-J. & Park, S.-Y. Mitochondrial transmembrane potential and reactive oxygen species generation regulate the enhanced effect of CCCP on TRAIL-induced SNU-638 cell apoptosis. J. Vet. Med. Sci. 70, 537-42 (2008).
58. Nobile, C. J. et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148, 126-38 (2012).
59. Zhu, Z. et al. Time course analysis of Candida albicans metabolites during biofilm development. J. Proteome Res. 12, 2375-85 (2013).
60. Van Acker, H. et al. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One 8, e58943 (2013).
61. Fonzi, W. A. & Irwin, M. Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717-728 (1993).
62. OBrien, J., Wilson, I., Orton, T. & Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267, 5421-5426 (2000).
63. Vriens, K. et al. Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures. PLoS One 10, e0132701 (2015).
64. Cao, Y.-Y. et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob. Agents Chemother. 49, 584-589 (2005).
65. Kim, D. et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
66. Arnaud, M. et al. Candida Genome Database. Available at http://www.candidagenome.org/Date of access: Throughout 2015.
67. Anders, S., Pyl, P. T. & Huber, W. HTSeq A Python framework to work with high-Throughput sequencing data. Bioinformatics 31, 166-9 (2015).
68. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
69. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289-300 (1995).
70. Skrzypek, M. S. et al. New tools at the Candida Genome Database: Biochemical pathways and full-Text literature search. Nucleic Acids Res. 38, D428-D432 (2009).
71. Mathys, J. et al. Genome-Wide Characterization of ISR Induced in Arabidopsis thaliana by Trichoderma hamatum T382 Against Botrytis cinerea Infection. Front. Plant Sci. 3, 108 (2012).
72. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-8 (2001).
73. Meletiadis, J., Verweij, P. E., TeDorsthorst, D. T. A., Meis, J. F. G. M. & Mouton, J. W. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models. Med. Mycol. 43, 133-152 (2005).
74. Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52, 1 (2003).
75. De Cremer, K. et al. Artemisinins, New Miconazole Potentiators Resulting in Increased Activity against Candida albicans Biofilms. Antimicrob. Agents Chemother. 59, 421-6 (2015).